Literature DB >> 25516298

T cell exhaustion and Interleukin 2 downregulation.

Mumtaz Y Balkhi1, Qiangzhong Ma2, Shazia Ahmad3, Richard P Junghans2.   

Abstract

T cells reactive to tumor antigens and viral antigens lose their reactivity when exposed to the antigen-rich environment of a larger tumor bed or viral load. Such non-responsive T cells are termed exhausted. T cell exhaustion affects both CD8+ and CD4+ T cells. T cell exhaustion is attributed to the functional impairment of T cells to produce cytokines, of which the most important may be Interleukin 2 (IL2). IL2 performs functions critical for the elimination of cancer cells and virus infected cells. In one such function, IL2 promotes CD8+ T cell and natural killer (NK) cell cytolytic activities. Other functions include regulating naïve T cell differentiation into Th1 and Th2 subsets upon exposure to antigens. Thus, the signaling pathways contributing to T cell exhaustion could be linked to the signaling pathways contributing to IL2 loss. This review will discuss the process of T cell exhaustion and the signaling pathways that could be contributing to T cell exhaustion.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chromatin; Exhaustion; Interleukin 2; PD1; T cells

Mesh:

Substances:

Year:  2014        PMID: 25516298     DOI: 10.1016/j.cyto.2014.11.024

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  20 in total

1.  Immunomodulatory glc/man-directed Dolichos lablab lectin (DLL) evokes anti-tumour response in vivo by counteracting angiogenic gene expressions.

Authors:  V Vigneshwaran; P Thirusangu; B R Vijay Avin; V Krishna; S N Pramod; B T Prabhakar
Journal:  Clin Exp Immunol       Date:  2017-04-05       Impact factor: 4.330

2.  Combined Inflammation and Metabolism Biomarker Indices of Robust and Impaired Physical Function in Older Adults.

Authors:  Xintong Zuo; Alison Luciano; Carl F Pieper; James R Bain; Virginia B Kraus; William E Kraus; Miriam C Morey; Harvey J Cohen
Journal:  J Am Geriatr Soc       Date:  2018-05-08       Impact factor: 5.562

3.  The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective.

Authors:  Richard P Junghans
Journal:  Cancer Gene Ther       Date:  2017-03       Impact factor: 5.987

4.  Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma.

Authors:  Geoffrey J Markowitz; Gregory A Michelotti; Anna Mae Diehl; Xiao-Fan Wang
Journal:  Sci Bull (Beijing)       Date:  2015-04-01       Impact factor: 11.780

5.  PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance.

Authors:  Alessandra Dondero; Fabio Pastorino; Mariella Della Chiesa; Maria Valeria Corrias; Fabio Morandi; Vito Pistoia; Daniel Olive; Francesca Bellora; Franco Locatelli; Aurora Castellano; Lorenzo Moretta; Alessandro Moretta; Cristina Bottino; Roberta Castriconi
Journal:  Oncoimmunology       Date:  2015-07-15       Impact factor: 8.110

6.  Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.

Authors:  Adrien Costantini; Catherine Julie; Coraline Dumenil; Zofia Hélias-Rodzewicz; Julie Tisserand; Jennifer Dumoulin; Violaine Giraud; Sylvie Labrune; Thierry Chinet; Jean-François Emile; Etienne Giroux Leprieur
Journal:  Oncoimmunology       Date:  2018-04-20       Impact factor: 8.110

7.  Accumulation of CD5+CD19+ B lymphocytes expressing PD-1 and PD-1L in hypertrophied pharyngeal tonsils.

Authors:  Paulina Wlasiuk; Artur Niedzielski; Katarzyna Skorka; Agnieszka Karczmarczyk; Joanna Zaleska; Malgorzata Zajac; Maciej Putowski; Elzbieta Pac-Kozuchowska; Krzysztof Giannopoulos
Journal:  Clin Exp Med       Date:  2015-08-29       Impact factor: 3.984

8.  ArtinM Mediates Murine T Cell Activation and Induces Cell Death in Jurkat Human Leukemic T Cells.

Authors:  Thiago Aparecido da Silva; Patrícia Kellen Martins Oliveira-Brito; Thiago Eleutério Gonçalves; Patrícia Edivânia Vendruscolo; Maria Cristina Roque-Barreira
Journal:  Int J Mol Sci       Date:  2017-06-30       Impact factor: 5.923

9.  Prevention of allograft rejection in heart transplantation through concurrent gene silencing of TLR and Kinase signaling pathways.

Authors:  Hongmei Wang; Xusheng Zhang; Xiufen Zheng; Zhu Lan; Jun Shi; Jifu Jiang; Terry Zwiep; Qing Li; Douglas Quan; Zhu-Xu Zhang; Weiping Min
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

10.  miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion.

Authors:  Qing Li; Nathan Johnston; Xiufen Zheng; Hongmei Wang; Xusheng Zhang; Dian Gao; Weiping Min
Journal:  Oncotarget       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.